Cambrex Corporation announced its plans to expand chemical and analytical development capabilities at its Charles City, Iowa Plant.
The project is intended to increase company’s development capacity and resources in North America. The expansion includes an additional 2, 000sq.ft. of laboratory space for development projects.
The building, installation, and validation of equipment are expected to be completed by Q1 2018. The development capacity involves the addition of 14 chemists’ jobs.
In parallel, a new 11, 000 sq.ft. analytical laboratory and 400 sq.ft. a pilot plant with a total reactor capacity of 4, 000 liters are currently being completed. These expansions at High Point will create up to 18 new jobs.
Cambrex’s Charles City, Iowa facility is located on a 45-acre site and manufactures a wide range of APIs and pharmaceutical intermediates, including highly potent molecules and controlled substances.